Valerie Wall
About Valerie Wall
Valerie Wall is a Scientist II at Notch Therapeutics in Seattle, Washington, with a strong background in cancer biology and immuno-oncology. She holds a Ph.D. in Pathology from the University of Washington and has over a decade of experience in developing cell-based assays and flow cytometry techniques.
Work at Notch Therapeutics
Valerie Wall has been employed at Notch Therapeutics as a Scientist II since 2021. Her role focuses on advancing research in immuno-oncology, particularly through the development of innovative methodologies for T cell differentiation and cancer therapeutics. Based in Seattle, Washington, she has contributed to the company's mission of harnessing the potential of engineered T cells for cancer treatment.
Education and Expertise
Valerie Wall earned her Bachelor of Science (BS) in Biochemistry from the University of Washington, studying from 2005 to 2007. She later pursued a Doctor of Philosophy (Ph.D.) in Pathology/Experimental Pathology at the same institution, completing her studies from 2010 to 2015. Her educational background has equipped her with a strong foundation in cancer biology and biochemistry, enabling her to develop advanced cell-based assays and high-throughput screening methods.
Background
Prior to her current role, Valerie Wall held multiple research positions. She was a Postdoctoral Researcher at both the Benaroya Research Institute at Virginia Mason and the University of Washington, where she focused on cancer research from 2015 to 2019. Additionally, she worked as a Research Technician at the Howard Hughes Medical Institute from 2007 to 2010. Her extensive experience spans over a decade in developing assays and conducting research in cancer biology.
Achievements
Valerie Wall has made significant contributions to the field of immuno-oncology through her research presentations at various conferences. She participated in ASGCT 2023, ISSCR 2023, and SITC 2023, focusing on T cell differentiation and the generation of functional CD8αβ T cells from iPSCs. Her work has been recognized in publications and presentations, showcasing her innovative approaches to complex scientific questions in cancer research.
Research Contributions
Valerie Wall has been actively involved in research initiatives that explore T cell differentiation and scalable production of iPSC-derived cells. Her contributions include research presented at Keystone 2023 and AACR Annual Meeting 2024, emphasizing the use of DLL4/VCAM beads and CAR iPSC T cells. These efforts reflect her commitment to advancing the understanding of immunotherapy and enhancing therapeutic strategies for cancer treatment.